Viveve Medical, Inc.: Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan

ENGLEWOOD, CO / ACCESSWIRE / July 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced

Related Keywords

Taiwan ,United States ,Scott Durbin ,Bill Berry ,Drug Administration ,Viveve Inc ,Taiwan Intellectual Property Office ,Nasdaq ,Viveve Medical Inc ,Berry Company Public Relations ,Securities Exchange ,Dynamic Medical Technologies Inc ,Viveve Medical ,Taiwan Patent ,Medical Technologies ,Cryogen Cooled Monopolar Radiofrequency ,Investigational Device Exemption ,Securities Act ,Securities Exchange Act ,Viveve Systems ,Viveve ,Medical ,Nnounces ,Expansion ,Portfolio ,Patent ,Issuance ,